A biotech startup leads a new effort to edit human embryos therapeutically, hoping technical advances will persuade ...
Editas Medicine (EDIT) traded higher on Thursday after Australian authorities cleared a Phase 1/2 trial for the company’s gene-editing therapy EDIT-401, and Wells Fargo upgraded the biotech to ...
A digital fruit fly brain quickly became an AI meme machine. It raises tough questions: could machines become conscious, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results